# FDA Inspection 1206004 - Healthcare Global City Cancer Centre - March 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/healthcare-global-city-cancer-centre/a2da21d6-9031-456b-99e2-994bc46adc6b
Source feed: FDA_Inspections

> FDA Inspection 1206004 for Healthcare Global City Cancer Centre on March 31, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206004
- Company Name: Healthcare Global City Cancer Centre
- Inspection Date: 2023-03-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1071883 - 2018-10-19](https://www.keypedia.com/records/fda_inspections/healthcare-global-city-cancer-centre/4b741f6d-8a55-4083-992b-c8d6bbd85ad8)

Company: https://www.keypedia.com/companies/healthcare-global-city-cancer-centre/5a93c4cc-e632-4066-8945-03bf2fa8a6c6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c